Susquehanna Fundamental Investments, LLC Novan, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.03 $97,757 - $168,298	-55,544 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.15 $22,568 - $45,640	-5,600 Reduced 9.16%	55,544 $232,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $10.17 $457,357 - $621,834	61,144 New	61,144 $498,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.